Allogene Therapeutics
ALLO
ALLO
116 hedge funds and large institutions have $1.86B invested in Allogene Therapeutics in 2019 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 38 increasing their positions, 26 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
2.33% more ownership
Funds ownership: 56.42% → 58.75% (+2.3%)
5% more call options, than puts
Call options by funds: $3.11M | Put options by funds: $2.97M
1% less capital invested
Capital invested by funds: $1.87B → $1.86B (-$11.5M)
Holders
116
Holding in Top 10
5
Calls
$3.11M
Puts
$2.97M
Top Buyers
| 1 | +$61.1M | |
| 2 | +$32.9M | |
| 3 | +$26.5M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$8.72M |
| 5 |
WCM
Wildcat Capital Management
New York
|
+$7.68M |
Top Sellers
| 1 | -$31.1M | |
| 2 | -$17.4M | |
| 3 | -$11M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$9.13M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$7.74M |